Abstract
The use of the serum of immunized goats as a means of preventing measles is comparatively new. Hoyne and Gasul 1 recently reported a series of cases in which goat serum was used for this purpose, and they showed that 88 per cent of their patients were protected against measles, the remaining 12 per cent developing mild attacks of the disease. Other methods of immunization against measles have been used. Nicolle and Conseil 2 and Richardson and Connor 3 used convalescent human measles serum as early as 1918. Rietschel 4 used convalescent human measles serum as early as 1918. Herrman 5 attempted to obtain active immunization by swabbing the mucous membranes of the nostrils of contacts with diluted secretions from patients with measles. All these methods, however, have definite disadvantages. Convalescent human serum is not usually obtainable in sufficient quantity when most desired, as in epidemics. Haas and Blum 6
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
